THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 101 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $103,500 | -4.6% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $108,500 | -15.9% | 10,000 | -13.0% | 0.00% | – |
| Q4 2022 | $129,030 | -77.7% | 11,500 | -79.8% | 0.00% | -100.0% |
| Q3 2022 | $578,000 | +341.2% | 57,000 | +293.8% | 0.00% | – |
| Q2 2022 | $131,000 | +1090.9% | 14,475 | +4725.0% | 0.00% | – |
| Q3 2016 | $11,000 | +450.0% | 300 | +200.0% | 0.00% | – |
| Q2 2016 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $78,677,176 | 13.94% |
| Irenic Capital Management LP | 1,700,937 | $19,084,513 | 9.15% |
| Weiss Asset Management LP | 7,457,060 | $83,668,213 | 3.41% |
| Newtyn Management, LLC | 1,450,000 | $16,269,000 | 3.36% |
| Palliser Capital (UK) Ltd | 97,100 | $1,089,462 | 2.65% |
| Chescapmanager LLC | 850,988 | $9,548 | 2.24% |
| Park West Asset Management LLC | 1,920,324 | $21,546,035 | 2.11% |
| Baupost Group | 11,419,226 | $128,124 | 2.09% |
| Saturn V Capital Management LP | 141,339 | $1,334,342 | 1.11% |
| Oasis Management Co Ltd. | 296,960 | $3,331,891 | 0.66% |